Syphilis: Understanding Its Resurgence and Prevention
"Explore the reasons behind the re-emergence of this old foe and what you can do to protect yourself and others."
Syphilis, caused by the bacterium Treponema pallidum, is a sexually transmitted infection (STI) that has seen a troubling resurgence in recent years. Once thought to be under control, this 'old foe' is back, posing a significant public health challenge globally. Understanding syphilis, its transmission, and prevention is more crucial than ever.
The World Health Organization (WHO) estimates that millions of new cases occur each year. Syphilis can have devastating consequences if left untreated, including damage to the cardiovascular and central nervous systems, and can even be fatal. Pregnant women with untreated syphilis can transmit the infection to their fetuses, leading to congenital syphilis, which causes significant health problems and infant mortality.
This article provides a detailed overview of syphilis, from its causes and symptoms to its treatment and prevention strategies. We'll explore the factors driving its re-emergence, particularly among high-risk groups, and discuss the latest approaches to combatting this infectious disease.
The Continuing Syphilis Burden
The CDC identifies chlamydia, syphilis, and gonorrhea as reportable sexually transmitted infections for which it provides the most recent national data. The World Health Organization describes syphilis as a curable infection caused by Treponema pallidum that can be transmitted through oral, vaginal, and anal sex, during pregnancy, and through unsafe blood transfusions. If untreated, it can persist for many years and cause serious health problems, while untreated, late-treated, or inadequately treated maternal syphilis can result in adverse birth outcomes.
What Causes Syphilis and How Is It Transmitted?
Treponema pallidum is typically transmitted through sexual contact with an infected individual. The bacterium enters the body through minor cuts or abrasions in the skin or mucous membranes. Syphilis can also be transmitted from a pregnant woman to her fetus during pregnancy or childbirth.
- Sexual contact (vaginal, anal, or oral sex)
- Mother-to-child transmission (MTCT) during pregnancy
Expanding Clinical Evidence
Recent research includes a narrative review that analyzed Centers for Disease Control and Prevention data from 2020 through 2024 using the National Notifiable Sexually Transmitted Infections Surveillance System to evaluate syphilis trends in the United States. A systematic review of nodular secondary syphilis searched PubMed and Embase through Elsevier and collected 144 published cases of nodular syphilis. A separate case report described syphilitic Charcot arthropathy involving the foot in an Asian patient, whose cerebrospinal fluid showed a VDRL titer of 1:8 and a positive syphilis CSF immunoglobulin G test.
Limits of Prevention and Diagnosis
Syphilis prevention remains constrained by the absence of a vaccine. Historical experience also shows that prevention strategies can depend on broader conditions: a review reports that changes in sexual behavior were more achievable in the 1980s because of the impact of HIV infection and the lack of an effective treatment. Current diagnostic reviews emphasize both the advantages and limitations of testing technologies for adults and newborns, alongside the need to update screening recommendations to reduce or eliminate transmission.
Stages, Follow-Up, and Treatment Options
Syphilis is a systemic disease caused by Treponema pallidum, and its stages are defined by clinical findings that guide treatment and follow-up. One clinical review reports that titers should decline fourfold within six months after treatment of primary or secondary syphilis, and within 12 to 24 months after treatment of latent or late syphilis. Treatment research is also examining alternatives to benzathine penicillin G: NIAID convened a workshop in February 2024 on alternative therapies for adult syphilis, neurosyphilis, and syphilis in pregnant persons and infants.
What Can We Do to Stop the Spread of Syphilis?
Syphilis remains a significant public health challenge, but with increased awareness, timely testing, and effective treatment, its spread can be controlled. By focusing on prevention, early detection, and comprehensive care, we can work towards a future where syphilis is no longer a threat to individual and public health.
Screening and Emerging Risk Assessment
A 2026 study is reevaluating the clinical utility of three syphilis testing algorithms amid increasing incidence and persistent prevalence. It examines cases from a large hospital in China with concurrent Treponema pallidum electrochemiluminescence immunoassay, T. pallidum particle agglutination, and toluidine red unheated serum test results. Research on machine learning has also identified a gap: previous reviews had not provided a comprehensive synthesis of machine-learning performance across HIV, syphilis, gonorrhea, and chlamydia or included a meta-analysis of machine-learning approaches for STIs.
Burden and Diagnostic Complexity
A study published in 2023 assessed the global, regional, and national burden of syphilis from 1990 to 2019 using disability-adjusted life-years and prevalence. Broader perspectives on sexually transmitted infections emphasize that case studies and real-world examples can show the lived experiences of people dealing with these diseases and the factors shaping their journeys. A clinical dual-case report further illustrates how syphilis can create diagnostic challenges because of its diverse clinical manifestations.